Evidence map›Paper›PMID 40756362›Full record

ArticleTheranostics2025

NIR-II light-driven

Yucheng Huang, Miao Su, Weihuan Lin, Peirong Zhang, Hengliang Hou, Fanjun Zeng, Luyu Huang, Qiaxuan Li, Jialong Deng, Shengbo Liu and 5 more

Abstract read
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nanovaccines for lung cancer: Platforms, mechanistic insights, and translational challenges.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yucheng HuangSchool of Medicine, South China University of Technology, Guangzhou, 510006, P. R. China.
Miao SuSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, 511442, P. R. China.
Weihuan LinSchool of Medicine, South China University of Technology, Guangzhou, 510006, P. R. China.
Peirong ZhangDepartment of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, P. R. China.
Hengliang HouSchool of Medicine, South China University of Technology, Guangzhou, 510006, P. R. China.
Fanjun ZengDepartment of General Practice, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, P. R. China.
Luyu HuangDepartment of Surgery, Competence Center of Thoracic Surgery, Charité Universitätsmedizin Berlin, Berlin, 10117, Germany.
Qiaxuan LiDepartment of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, P. R. China.
Jialong DengSchool of Medicine, South China University of Technology, Guangzhou, 510006, P. R. China.
Shengbo LiuSchool of Medicine, South China University of Technology, Guangzhou, 510006, P. R. China.
Hongrui QiuDepartment of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, P. R. China.
Xiaoqing YuanMedical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, P. R. China.
Li PengMedical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, P. R. China.
Bin XuSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, 511442, P. R. China.
Haiyu ZhouSchool of Medicine, South China University of Technology, Guangzhou, 510006, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer VaccinesImmunotherapyLymph NodesNanoparticlesNeoplasmsAdjuvants, ImmunologicAnimalsAntigens, NeoplasmCell Line, TumorDendritic CellsFemaleHumansInfrared RaysMiceMice, Inbred C57BLNanovaccinesAdjuvants, ImmunologicAntigens, NeoplasmCancer VaccinesNanovaccinesimmunotherapylymph node migrationnanovaccinesviscous nanoparticles

Identifiers

PMID40756362
PMCPMC12316039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.